473 related articles for article (PubMed ID: 19541712)
1. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial.
van Beek EJ; Dahmen AM; Stavngaard T; Gast KK; Heussel CP; Krummenauer F; Schmiedeskamp J; Wild JM; Søgaard LV; Morbach AE; Schreiber LM; Kauczor HU
Eur Respir J; 2009 Dec; 34(6):1311-21. PubMed ID: 19541712
[TBL] [Abstract][Full Text] [Related]
2. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
[TBL] [Abstract][Full Text] [Related]
3. Hyperpolarized 3He MRI and 81mKr SPECT in chronic obstructive pulmonary disease.
Stavngaard T; Søgaard LV; Mortensen J; Hanson LG; Schmiedeskamp J; Berthelsen AK; Dirksen A
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):448-57. PubMed ID: 15821964
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary
Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
[TBL] [Abstract][Full Text] [Related]
5. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes.
Fan L; Xia Y; Guan Y; Zhang TF; Liu SY
Clin Respir J; 2014 Jan; 8(1):45-54. PubMed ID: 23711228
[TBL] [Abstract][Full Text] [Related]
6. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.
Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Takahashi M; Van Cauteren M; Sugimura K
AJR Am J Roentgenol; 2011 Aug; 197(2):W279-85. PubMed ID: 21785054
[TBL] [Abstract][Full Text] [Related]
7. Hyperpolarized (3)He magnetic resonance imaging-derived pulmonary pressure-volume curves.
Choy S; Wheatley A; McCormack DG; Parraga G
J Appl Physiol (1985); 2010 Aug; 109(2):574-85. PubMed ID: 20538846
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
[TBL] [Abstract][Full Text] [Related]
9. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.
Ohno Y; Iwasawa T; Seo JB; Koyama H; Takahashi H; Oh YM; Nishimura Y; Sugimura K
Am J Respir Crit Care Med; 2008 May; 177(10):1095-102. PubMed ID: 18276941
[TBL] [Abstract][Full Text] [Related]
10. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
[TBL] [Abstract][Full Text] [Related]
11. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla.
Parraga G; Ouriadov A; Evans A; McKay S; Lam WW; Fenster A; Etemad-Rezai R; McCormack D; Santyr G
Invest Radiol; 2007 Jun; 42(6):384-91. PubMed ID: 17507809
[TBL] [Abstract][Full Text] [Related]
12. Severity-related differences in lung attenuation in men with COPD.
Torres I; Allona M; Martínez M; Lores V; Rojo B; García-Río F
Arch Bronconeumol; 2010 Feb; 46(2):56-63. PubMed ID: 19896258
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 magnetic resonance imaging: differences in COPD and relationship to emphysema.
Kirby M; Svenningsen S; Kanhere N; Owrangi A; Wheatley A; Coxson HO; Santyr GE; Paterson NA; McCormack DG; Parraga G
J Appl Physiol (1985); 2013 Mar; 114(6):707-15. PubMed ID: 23239874
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Imaging Phenotypes of Chronic Obstructive Pulmonary Disease Using Multiparametric Response Maps.
MacNeil JL; Capaldi DPI; Westcott AR; Eddy RL; Barker AL; McCormack DG; Kirby M; Parraga G
Radiology; 2020 Apr; 295(1):227-236. PubMed ID: 32096708
[TBL] [Abstract][Full Text] [Related]
15. Progression of emphysema evaluated by MRI using hyperpolarized (3)He (HP (3)He) measurements in patients with alpha-1-antitrypsin (A1AT) deficiency compared with CT and lung function tests.
Stavngaard T; Søgaard LV; Batz M; Schreiber LM; Dirksen A
Acta Radiol; 2009 Nov; 50(9):1019-26. PubMed ID: 19863412
[TBL] [Abstract][Full Text] [Related]
16. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD.
O'Donnell RA; Peebles C; Ward JA; Daraker A; Angco G; Broberg P; Pierrou S; Lund J; Holgate ST; Davies DE; Delany DJ; Wilson SJ; Djukanovic R
Thorax; 2004 Oct; 59(10):837-42. PubMed ID: 15454648
[TBL] [Abstract][Full Text] [Related]
17. Airway wall thickness in patients with COPD and healthy current smokers and healthy non-smokers: assessment with high resolution computed tomographic scanning.
Deveci F; Murat A; Turgut T; Altuntaş E; Muz MH
Respiration; 2004; 71(6):602-10. PubMed ID: 15627871
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Assessment of Airway Pathology in Subjects With COPD Using Low-Dose High-Resolution Computed Tomography.
Chen H; Chen GQ; Zeng QS; Xia TT; Zhou JX; Qiu SJ
Respir Care; 2017 Jul; 62(7):953-962. PubMed ID: 28424225
[TBL] [Abstract][Full Text] [Related]
19. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD.
Ohno Y; Koyama H; Nogami M; Takenaka D; Matsumoto S; Obara M; Sugimura K
AJR Am J Roentgenol; 2008 Feb; 190(2):W93-9. PubMed ID: 18212207
[TBL] [Abstract][Full Text] [Related]
20. Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease.
Kirby M; Svenningsen S; Owrangi A; Wheatley A; Farag A; Ouriadov A; Santyr GE; Etemad-Rezai R; Coxson HO; McCormack DG; Parraga G
Radiology; 2012 Nov; 265(2):600-10. PubMed ID: 22952383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
